首页> 外国专利> The compound, pharmaceutical composition and method for treatment of tumors, a process for the synthesis of umcomposto.

The compound, pharmaceutical composition and method for treatment of tumors, a process for the synthesis of umcomposto.

机译:该化合物,药物组合物和用于治疗肿瘤的方法,一种合成umcomposto的方法。

摘要

A compound according to formula (I): CHEM wherein R is C1-C10 alkyl; phenyl or C7-C10 aralkyl; C2-C10 aklyl substituted with one or two substituents selected from the group consisting of OR1 and -NR2R3; C2-C10 alkyl interrupted by one or two oxygen atoms or by a member selected from the group consisting of -NR4-, cis -CH=CH, trans -CH=CH- and -C=C-, and optionally substituted with one or two hydroxy (OH) or -NR2R3 groups; and wherein R1 is selected from the group consisting of hydrogen, C1-C6 alkyl, phenyl, C7-C10 aralkyl, -CHO, -COR5-, -COOR5, -S(O2)R5 and C2-C6 alkyl optionally substituted with -NR2R3; R2 and R3 are the same or different and are selected from the group consisting of hydrogen, C1-C10 alkyl, C7-C10 aralkyl, phenyl, C2-C10 alkyl substituted with one or two hydroxy (OH) groups, -CHO, -COR5, -COOR5, and -S(O2)R5, R2 and R3 taken together with the nitrogen atom to which they are bound form an ethyleneimine ring or a 5- or 6-membered aromatic or non-aromatic heterocyclic ring optionally containing another heteroatom selected from the group consisting of sulfur, oxygen and nitrogen, R2 is H and R3 is -C(=NH)NH2 or R2 is -C(=NH)NH2 and R3 is H; R4 is selected from the group consisting of hydrogen, C1-C10 alkyl, C2-C10 hydroxyalkyl, C2-C10 alkyl substituted with -NR2R3, C7-C10 aralkyl, phenyl, -COR5, -COOR5 and -S(O2)R5; R5 is selected from the group consisting of C1-C10 alkyl, C7-C10 aralkyl, alpha -, beta -, or gamma -naphthyl, phenyl, o-, m-, or p-tolyl as free bases and their salts with pharmaceutically acceptable acids, have been found to have cytostatic and anti-tumor activity.
机译:式(I)的化合物:其中R为C1-C10烷基;苯基或C 7 -C 10芳烷基;被一个或两个选自OR1和-NR2R3的取代基取代的C2-C10烷基;被一个或两个氧原子或被选自-NR 4-,顺式-CH = CH,反式-CH = CH-和-C = C-的组中的成员中断的C 2 -C 10烷基,并且任选地被一个或多个取代两个羟基(OH)或-NR2R3基团;其中R1选自氢,C1-C6烷基,苯基,C7-C10芳烷基,-CHO,-COR5-,-COOR5,-S(O2)R5和任选被-NR2R3取代的C2-C6烷基; R 2和R 3相同或不同,并且选自氢,C 1 -C 10烷基,C 7 -C 10芳烷基,苯基,被一个或两个羟基(OH)取代的C 2 -C 10烷基,-CHO,-COR5 ,-COOR5和-S(O2)R5,R2和R3与它们所键合的氮原子一起形成亚乙基亚胺环或5或6元芳族或非芳族杂环,其任选地包含选择的另一个杂原子选自硫,氧和氮,R 2为H,R 3为-C(= NH)NH 2或R 2为-C(= NH)NH 2,且R 3为H。 R4选自氢,C1-C10烷基,C2-C10羟烷基,被-NR2R3取代的C2-C10烷基,C7-C10芳烷基,苯基,-COR5,-COOR5和-S(O2)R5; R5选自C1-C10烷基,C7-C10芳烷基,α-,β-或γ-萘基,苯基,邻-,间-或对-甲苯基作为游离碱及其与药学上可接受的盐已经发现,酸具有细胞生长抑制和抗肿瘤活性。

著录项

  • 公开/公告号BR9205740A

    专利类型

  • 公开/公告日1994-09-27

    原文格式PDF

  • 申请/专利权人 THE UNIVERSITY OF VERMONT;

    申请/专利号BR19929205740

  • 发明设计人 KRAPCHO P.;

    申请日1992-03-09

  • 分类号C07D419/14;C07D413/14;C07D403/14;C07D221/08;A61K31/435;A61K31/53;A61K31/495;

  • 国家 BR

  • 入库时间 2022-08-22 04:46:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号